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Abstract 
At an early stage of oxidation induced by Cu*+, the rate of oxidative modification of human low density lipoprotein (LDL) from healthy donors 
correlated negatively to its ubiquinol-10 (r = -0.58, P < 0.01) and positively to its polyunsaturated fatty acid (PUFA) (r = 0.53, P < 0.05) content. 
The PUFA/ubiquinol-10 ratio was the best predictor of LDL susceptibility to oxidation (r = 0.68, P < 0.01). No significant correlation between LDL 
oxidiibility and its a-tocopherol content was found at any oxidation stage. It is suggested that ubiquinol-10 plays a central role in the early protection 
of LDL PUFAs against Cu’+-induced oxidation whereas a-tocopherol posesses both pro- and antioxidant activity. 
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1. Introduction 
Much evidence exists to implicate the oxidation of low 
density lipoprotein (LDL) in the early development of 
atherosclerosis [1,2]. Owing to this implication, a possi- 
ble conjunction between oxidizability and chemical com- 
position of human LDL has recently been extensively 
studied [3,4]. The relative importance of different LDL 
constituents in the prevention of LDL oxidation, how- 
ever, remains unclear. 
It can be assumed that LDL antioxidant content 
should be one of the most important factors determining 
LDL susceptibility to oxidation. It is well established 
that a-tocopherol is, on a molar base, the major antiox- 
idant in LDL [3,4]. All other antioxidants (y-tocopherol, 
carotenoids, ubiquinol-10) are present in LDL in much 
smaller amounts. However, a number of researchers 
have found no correlation between a-tocopherol content 
and susceptibility to oxidation in native LDL not supple- 
mented with antioxidants [5-121. It has been shown that 
ubiquinol-10 can protect human LDL more efficiently 
against lipid peroxidation than cc-tocopherol[l3-151, de- 
spite the much higher LDL content of the latter. 
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Abbreviations; EDTA, ethylenediaminetetraacetic acid; HPLC, high- 
performance liquid chromatography; LDL, low density lipoprotein; 
MUFA, monounsaturated fatty acid; PBS, phosphate-buffered saline; 
PUFA, polyunsaturated fatty acid, TBARS, thiobarbituric acid-reac- 
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LDL oxidizability may also depend on an amount of 
oxidizable substrate available within the LDL particle, 
i.e. on LDL polyunsaturated fatty acid (PUFA) content: 
it was recently reported that the linoleic-to-oleic acid 
ratio correlates positively to the oxidizability of native 
LDL not enriched in fatty acid [16]. Some other factors, 
such as initial LDL hydroperoxide [17,18] or protein 
[14,16] content, may also play an important role in the 
process of LDL oxidation. 
In order to better understand how different LDL con- 
stituents might influence its susceptibility to oxidation, 
we characterized antioxidant as well as total composition 
of human LDL and compared each with LDL oxidizabil- 
ity by copper, measured as accumulation of conjugated 
dienes in the LDL sample. The results suggest hat, at an 
early stage of the oxidation, protection of LDL PUFAs 
is provided mainly by ubiquinol-10 while ol-tocopherol 
functions as a pro- rather than an antioxidant. Conse- 
quently, LDL ubiquinol-10 and PUFA contents presum- 
ably represent he most important factors determining the 
susceptibility of LDL to the copper-induced oxidation. 
2. Materials and methods 
2.1. Chemicals 
Ubiquinone-10, ubiquinone-9, a-tocopherol and &tocopherol were 
obtained from Fluka (Neu-Uhn, Germany). All other chemicals and 
solvents were from Sigma (Deisenhofen, Germany) or Merck (Darm- 
stadt, Germany). Ubiquinol-9 was prepared from ubiquinone-9 by re- 
duction with sodium dithionite [19]. 
2.2. Isolation and characterization of LDL 
LDL was isolated using density gradient ultracentrifugation of 
human plasma for 20 h at 4°C in the presence of 1.5 mM EDTA [20]. 
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Plasma was obtained by low-speed centrifugation of blood from 20 
apparently healthy donors aged 22-51 years (mean 34.3) who were on 
neither an antioxidant nor a fatty acid diet. Blood taken in EDTA- 
containing tubes was immediately centrifuged at 4°C for 10 min. 
Ubiquinol-10, ubiquinone-10, a-tocopherol and y-tocopherol con- 
tent of LDL was quantified immediately after LDL isolation by re- 
versed-phase HPLC with electrochemical detection (Finckh, B., unpub- 
lished data). Briefly, 100 ~1 LDL was mixed with 100 ~1 ethanol con- 
taining necessary amounts of ubiquinol-9, ubiquinone-7 and S-tocophe- 
rol as internal standards. After adding 100 ~1 water and 500 ~1 hexane, 
the mixture was vortexed, centrifuged and the hexane extract was col- 
lected and evaporated under argon. The residue was dissolved in 125 
~1 reagent al~ho~metha~ol (1:l v/v) and subjected to HPLC with a 
Coulochem 5lOOA electrochemical detector (Environmental Sciences 
Assoc., Bedford, MA, USA) equipped with a Model 5011 analytical cell 
and a Model 5020 conditioning cell. The system was set as follows: 
conditioning cell -0.60 V, detector 1 -0.15 V, detector 2 +0.60 V. A 
methanol/ethanol!2-propanol(l,O25:451:24 v/v) mixture containing 13 
mM lithium perchlorate was used as a mobile phase at a Sow rate of 
1.2 mllmin. 
Total cholesterol, free cholesterol, triglyceride, phospholipid and 
total lipid content of LDL were determined with commercially available 
enzymatic kits. LDL cholesterol ester content was calculated from the 
values obtained. Total protein was measured with the Pierce reagent 
(Pierce, Oud-Beijerland, The Netherlands) using human serum albumin 
as a standard. Fatty acid composition of LDL was characterized by 
capillary gas chromatography as described elsewhere f2lJ. Absolute 
amounts of fatty acids in LDL were calculated using the data on LDL 
lipid composition assuming that the lipoprotein does not contain any 
free fatty acids. 
LDL TBARS were measured using 0.375% thiobarbituric acid and 
15% trichloroacetic acid dissolved into 0.25 M HCl [22]. Lipid perox- 
ides were estimated with Merck CHOD-iodide cholesterol color reagent 
(Merck, Darmstadt, Germany) [23]. 
To recalculate the values obtained into moUmo1 LDL, an LDL mo- 
lecular weight of 2.5106 was used 141. 
2.3. Oxidation of LDL 
Immediately after LDL isolation, EDTA and potassium bromide 
were removed from the LDL suspension by gel filtration on Sephadex 
PD-10 columns (Sephadex G-25M; Pharmacia Fine Chemicals, 
Uppsala, Sweden). The EDTA-free LDL suspension was diluted with 
phosphate-buffered saline (PBS) to a final cholesterol concentration of 
0.12 mg/ml (approximately 0.14 PM LDL) and the oxidation was 
started by addition of freshly prepared copper sulphate to a final con- 
centration of 2.0 PM. All the oxidation experiments were performed at 
25°C and completed within 30 h from the moment of blood collection. 
The level of LDL oxidation was estimated by accumulation of conju- 
gated dienes in the LDL sample. Conjugated dienes were measured 
according to Esterbauer et al. [24] as an increase in the absorption of 
the sample at 234 nm. Duration of the lag-phase of diene accumulation 
was calculated from the time courses obtained (see Fig. 1). 
3. Results 
LDL used in the experiments revealed no abnormali- 
ties in chemical composition (Table 1). LDL content of 
the main lipid classes corresponded well with data pub- 
lished elsewhere [3,4]. The LDL concentration of ubiqui- 
nol-10 was almost 3-fold higher than that reported by 
Esterbauer et al. [4] but about 2-fold lower than that 
reported by Bowry et al. [25]. It is well known that ubiq- 
uinol-10 is a highly unstable compound and easily oxi- 
dized into the corresponding quinone, even under careful 
handling [26]. Hence, the apparent discrepancy found 
might simply be due to the fact that our LDL isolating 
procedure lasted longer than that of Bowry et al. [25] but 
was shorter than that of Esterbauer et al. [4]. 
LDL content of ubiquinone-10 ranged within previ- 
ously reported values [25,27]. LDL content of a-tocophe- 
rol and y-tocopherol, as well as of major classes of fatty 
acids, corresponded well with reference values 141. Lipid 
peroxidation products (lipid peroxides measured 
iodometrically and TBARS) were slightly decreased in 
our LDL as compared with others [4], also presumably 
due to our relatively short procedure for isolating LDL. 
Incubation of LDL with CL? (about 17 Cu*’ ions per 
1 LDL particle) led to the oxidation of the lip,oprotein 
as judged by accumulation of conjugated dienes in the 
LDL sample (Fig. 1). This was confirmed by parallel 
measurements of TBARS and lipid peroxides (data not 
shown). The time-course of diene accumulation was sim- 
ilar to that originally reported by Esterbauer et al. [24]. 
The oxidation was characterized by a distinct lag-phase 
(100.2 + 25.4 min) followed by propagation and decom- 
position phases. 
In accordance with previous findings f4,7,8], no signif- 
icant correlation was found between the duration of the 
lag-phase of diene ambulation and the initial LDL 
content of a-tocopherol (I = 0.295, P = 0.207) or 
PUFAs (r = 0.097, P = 0.684). Nor was a significant cor- 
relation found between the duration of the lag-phase and 
initial LDL ubiquinol-IO concentration (r = 0.160, 
P = 0.501). Nevertheless, when the data were examined 
as rates of diene accumulation measured between defi- 
nite moments within the lag-phase (see Fig. l), a series 
of significant correlations were found (Fig. 2). The corre- 
lations were only significant at an early stage of LDL 
Table 1 
Chemical composition of LDL preparations 
Compound 
Ubiquinol-10 
Ubiquinone- 10 
Total ubiq~none-10 + 
ubiquinol-10 
a-Tocopherol 
y-Tocopherol 
PUFAs 
MUFAs 
Saturated fatty acids 
Double bond index 
Lipid peroxides 
TBARS 
LDL content 
(moYmo1 LDL) 
-- 
0.280 f 0.071 
0.263 + 0.121 
0.543 f 0.153 
6.11 + 2.63 
0.56 + 0.20 
1,194 f 224 
536 f 66 
676 + 56 
1.05 + 0.17 
3.69 ? 2.76 
0.16 + 0.10 
Percent of total LDL weight 
Cholesterol esters 41.0 + 4.3 
Free cholesterol 10.5 f 2.5 
Total cholesterol 33.8 * 3.3 
Phospholipids 18.5 + 2.1 
Triglycerides 4.7 + 1.7 
Total lipids 74.7 + 4.6 
Total protein 25.3 f 4.6 
Data are presented as means & SD. LDL (n = 20) was isolated from 
freshly collected plasma using density gradient ultra~ntrifugation for 
20 h at 4°C. EDTA was present at all steps of isolation. 
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Fig. 1. Accumulation of conjugated ienes in LDL samples measured 
as an increase of the absorbance of the sample at 234 nm after addition 
of Cu2’. The curve was averaged for 20 samples tudied. The straight 
lines illustrate the lag-phase calculation method [4]. The arrows show 
the moments used for calculation of correlations. LDL concentration, 
0.12 mg total cholesterol/ml; Cu2’ concentration, 2.0 PM; temperature 
25°C. 
oxidation, i.e. within the first part of the lag-phase (mak- 
ing up approximately 3650% of the total duration of the 
lag-phase). The rate of LDL oxidation measured be- 
tween 10 and 30 min of oxidation and the initial LDL 
ubiquinol-10 content correlated negatively (P < 0.01) 
(Fig. 2A). The rate of LDL oxidation measured within 
the same period correlated positively (P < 0.05) with the 
initial LDL content of PUFAs (Fig. 2C). Upon analysis 
of the PUFAs/ubiquinol-10 ratio, the correlations 
yielded an even greater significance (Fig. 2D). The early 
(10-30 min) LDL oxidizability also correlated positively 
(P c 0.05) with the ratio of LDL content of PUFAs over 
that of monounsaturated fatty acids (MUFAs) (Fig. 2F). 
All correlations were most pronounced when measured 
between 10 and 30 min of incubation with Cu*+ and 
became less or non-significant at later stages of oxida- 
tion. No significant correlation was found between the 
variables shown in Fig. 2 and an initial rate of LDL 
oxidation measured after 10 min of incubation. 
In contrast to ubiquinol- 10 and PUFAs, no significant 
correlation was found between LDL content of a-toco- 
pherol and the rate of diene accumulation within any 
period studied (Fig. 2B). However, it should be noted 
that the correlation tended to be positive at early stages 
and negative at later stages of oxidation induced by Cu*+. 
Similarly, no significant correlation was found between 
PUFAsla-tocopherol ratio and the rate of LDL oxida- 
tion despite a tendency towards a positive correlation at 
the later stages of the oxidation (Fig. 2E). The values of 
the rate of diene accumulation measured between 10 and 
1 
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Fig. 2. Correlation coefficients between rate of diene accumulation in LDL samples measured within different periods (between 0 and 10, 10 and 
30, 30 and 60,60 and 90,90 and 120 mm of oxidation) and initial LDL content of ubiquinol-10 (A), a-tocopherol (B) and PUFAs (C). Analogous 
correlation coefficients for PUFAsktbiquinol-10 (D), PUFAsla-tocopherol (E) and PUFAs/MUFAs (F) are also shown. Numbers on the curves 
denote correlation coefficients calculated within definite periods. LDL concentration, 0.12 mg total cholesterol/ml; Cu*’ concentration, 2.0 PM; 
temperature 25°C. *P < 0.05; **P < 0.01. 
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30 min of oxidation and LDL contents of ubiquinol-10, 
a-tocopherol and PUFAs for all the samples tudied are 
shown in Table 2. 
4. Discussion 
At an early stage of oxidation induced by Cu*+, i.e. 
within the first part of the lag-phase of diene accumula- 
tion, the rate of oxidative modification of human LDL 
correlated significantly with its ubiquinol-10 and PUFA 
content. On the other hand, no significant correlation 
between LDL oxidizability and its a-tocopherol content 
was found. 
The correlation between the rate of LDL oxidation 
and its ubiquinol-10 content was found to be negative, 
suggesting that quinol delays the oxidation in the early 
phase. Ubiquinol-10 is known to be a powerful lipid- 
soluble antioxidant towards protection of unsaturated 
lipids in various model and biological systems [28]. 
Stocker et al. [ 131 found a high antioxidative activity of 
ubiquinol-10 in human LDL, and that, as long as ubiqui- 
nol- 10 is present, no significant amounts of hydroperox- 
ides are accumulated in LDL. Hence, our correlation 
may be explained by the inhibitory action of the quinol 
on LDL lipid peroxidation. Stocker et al. 1131 also dem- 
Table 2 
Values of LDL content of ubiquinol-10, a-tocopherol and PUFAs and 
rate of LDL oxidation measured between 10 and 30 min of incubation 
with copper in all the LDL samples studied 
Ubiquinol-10 a-Tocopherol PUFAs 
(mol/mol (mol/mol (mol/mol 
LDL) LDL) LDL) 
0.174 5.39 1,560 
0.277 8.34 1,401 
0.276 3.90 1,217 
0.206 3.10 1,315 
0.272 3.35 1,111 
0.265 6.88 1,034 
0.286 5.95 717 
0.313 5.80 911 
0.315 4.46 1,233 
0.384 5.11 1,180 
0.444 4.53 1,006 
0.314 2.64 1,161 
0.335 5.12 1,043 
0.196 12.99 1,260 
0.334 4.58 1,368 
0.270 11.44 1,572 
0.218 8.41 1,431 
0.187 5.87 1,209 
0.187 6.43 1,298 
0.338 7.31 852 
Rate of LDL 
oxidation 
(units of absorb- 
ance) 
--- 
0.063 
0.045 
0.018 
0.033 
0.008 
0.035 
0.014 
0.022 
0.025 
0.022 
0.008 
0.030 
0.036 
0.030 
0.011 
0.026 
0.035 
0.041 
0.020 
0.010 
Rate of LDL oxidation (0.12 mg total LDL cholestero~ml, 2gM Cu”, 
25Y.Z) is expressed as an increase of absorbance of LDL sample at 234 
nm between 10 and 30 min of oxidation. 
onstrated that ubiquinol-10 is consumed long before c1- 
tocopherol during in vitro LDL oxidation. Our discov- 
ered existence of a correlation only at an early stage of 
oxidation is in accordance with this finding. 
How ubiquinol- 10 functions as an LDL antioxidant is 
unclear at present. It is generally assumed that the quinol 
can eliminate free radicals formed directly by their scav- 
enging [29-311 and/or indirectly through the recycling of 
LDL ~-tocopherol [32,33]. Whatever the exact mecha- 
nism, however, the antioxidative activity of ubiquinol- 10 
appears to be high enough to inhibit LDL oxidation until 
all the quinol is consumed. It has been shown that ubiq- 
uinol-10 scavenges peroxyl radicals and regenerates a- 
tocopherol radicals in an hydrophobic medium at a rate 
constant of about 104-105.M-‘*s-’ (31,341. On the other 
hand, an initial step of LDL oxidation by Cu2+ presuma- 
bly occurs at a rate which is at least several orders lower 
[15]. The suggestion of a central role of ubiquinol-10 in 
the early protection of LDL against Cu*‘-induced oxida- 
tion corresponds well with these observations. 
The correlation between the LDL oxidizability and its 
PUFA content in the present study was found to be 
positive, suggesting an increased rate of LDL oxidation 
in samples rich in unsaturated lipids. It appears quite 
obvious that the rate of lipid peroxidation depends on 
the amount of substrate available for the process. Recent 
findings have demonstrated an increased LDL suscepti- 
bility to oxidation in subjects on a PUFA-enriched diet 
[35]. Our discovered positive correlation between LDL 
oxidizability and its PUFAs/MUFAs ratio also corre- 
sponds well to the positive correlation between linoleic- 
to-oleic acid ratio and o~d~bi~ty of LDL not enriched in 
fatty acid [16]. Altogether, these data underline the role 
of PUFAs in enhancing the process of LDL oxidation. 
The lack of a significant correlation between the rate 
of diene accumulation and LDL a-tocopherol content 
points to a complex effect of this compound on LDL 
oxidation. The correlation tended to be positive at early 
and negative at later stages of Cu”-induced oxidation. 
This time-course might be explained by the prevalence 
of a prooxidant activity of the vitamin at early stages and 
an antioxidant activity at later stages of oxidation. The 
fact that the correlation between LDL PUFAs/~-toco- 
pherol ratio and the rate of diene accumulation tended 
to be positive at the later stages of oxidation corresponds 
well with this assumption. Prooxidant action of a-toco- 
pherol on the process of LDL oxidation has been found 
by Bowry et al. [36]. According to their proposed 
scheme, a free radical of a-tocopherol, if present in the 
LDL particle for a sui%cient ime (at low free radical 
tluxes), can initiate peroxidation of LDL PUFAs. Obvi- 
ously, this mechanism can not be valid in our case be- 
cause of the high copper concentration used (17 Cu2+ 
ions per 1 LDL particle), which corresponds to signifi- 
cantly higher free radical fluxes fl5]. 
The second possibility involves a participation of CX- 
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tocopherol in the initiation of lipid peroxidation by CU’+ 
[4]. Presumably, this process begins with one-electron 
reduction of Cu2+ to Cu2+ by an unknown reductant. 
Recently, it has been shown that in deoxycholate micelles 
a-tocopherol can be easily oxidized by Cu2’ [18]. Under 
similar conditions, a-tocopherol incorporated into phos- 
pholipid liposomes rapidly reduced Fe3+ to Fe” [37]. 
This suggests that a-tocopherol can also function as a 
reductant for Cu2+ in a course of LDL oxidation, provid- 
ing an initial step of the process [4]. This scheme might 
explain the weak positive correlation between the rate of 
diene accumulation and LDL ol-tocopherol content that 
we observed within the first 30 min of oxidation. On the 
other hand, the weak negative correlation observed later 
might correspond to the classical scavenging of free rad- 
icals by a-tocopherol at high free radical fluxes. The 
weakness of both correlations might be due to the exis- 
tence of the two concurrent processes at all the stages of 
oxidation. 
The prevalence of the prooxidant activity of a-toco- 
pherol at early stages of LDL oxidation supports the 
suggestion of a crucial role of ubiquinol-10 in the early 
protection of LDL PUFAs. It has been reported that 
under conditions of a constant flux of water-soluble per- 
oxyl radicals, a-tocopherol provides almost 90% of the 
total radical-trapping capacity of human LDL, whereas 
ubiquinol-10 contributes insignificantly to the overall 
trapping [12]. However, at early stages of oxidation in- 
duced by Cu2’, when a-tocopherol acts as a pro- rather 
than antioxidant, ubiquinol-10 might represent he only 
actual antioxidant in LDL. 
Finally, it should be mentioned that the mechanism of 
early LDL oxidation may be of great importance in vivo 
where the oxidation of LDL in the arterial wall can give 
rise to the formation of early atherosclerotic lesions [l]. 
It has been suggested that mild rather than extensive 
oxidation of LDL might be responsible for the athero- 
genie properties of this lipoprotein [38]. In our study, the 
PUFAs/ubiquinol-10 ratio was the best predictor of the 
early LDL oxidation. Hence, the ubiquinol-10 and 
PUFA content of LDL might represent an important 
factor influencing the early development of such lesions. 
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